KR20230051199A - 세페타프로스트를 함유하는 의약 제제 - Google Patents
세페타프로스트를 함유하는 의약 제제 Download PDFInfo
- Publication number
- KR20230051199A KR20230051199A KR1020237006743A KR20237006743A KR20230051199A KR 20230051199 A KR20230051199 A KR 20230051199A KR 1020237006743 A KR1020237006743 A KR 1020237006743A KR 20237006743 A KR20237006743 A KR 20237006743A KR 20230051199 A KR20230051199 A KR 20230051199A
- Authority
- KR
- South Korea
- Prior art keywords
- glaucoma
- ocular hypertension
- treatment
- cefetaprost
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020136796 | 2020-08-13 | ||
| JPJP-P-2020-136796 | 2020-08-13 | ||
| PCT/JP2021/029701 WO2022034909A1 (ja) | 2020-08-13 | 2021-08-12 | セペタプロストを含有する医薬製剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20230051199A true KR20230051199A (ko) | 2023-04-17 |
Family
ID=80248014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020237006743A Pending KR20230051199A (ko) | 2020-08-13 | 2021-08-12 | 세페타프로스트를 함유하는 의약 제제 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230285411A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4197540A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2022034909A1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230051199A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115768433A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202220666A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022034909A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202404569A (zh) | 2022-04-22 | 2024-02-01 | 日商參天製藥股份有限公司 | 含有賽佩普斯特(Sepetaprost)之眼科用組合物 |
| TW202517277A (zh) * | 2023-10-10 | 2025-05-01 | 日商參天製藥股份有限公司 | 含有賽佩普斯特(Sepetaprost)之點眼液 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011013651A (ja) | 2009-07-03 | 2011-01-20 | Mitsumasa Maeda | フレキシブルディスプレイのれん |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101768235B1 (ko) | 2009-07-28 | 2017-08-14 | 오노 야꾸힝 고교 가부시키가이샤 | 이환식 화합물 및 이의 의약 용도 |
| WO2019124489A1 (ja) * | 2017-12-21 | 2019-06-27 | 参天製薬株式会社 | セペタプロストとep2アゴニストとの組み合わせ医薬 |
| EP3730138B1 (en) * | 2017-12-21 | 2024-02-14 | Santen Pharmaceutical Co., Ltd. | Combination of sepetaprost and ripasudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension |
| US11666563B2 (en) * | 2017-12-28 | 2023-06-06 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical preparation containing pyridyl aminoacetic acid compound |
| JP2022508715A (ja) * | 2018-10-15 | 2022-01-19 | オキュフィア・ファーマ・インコーポレイテッド | 緑内障および関連状態の処置のための方法および組成物 |
-
2021
- 2021-08-12 JP JP2022542874A patent/JPWO2022034909A1/ja active Pending
- 2021-08-12 EP EP21855988.8A patent/EP4197540A4/en active Pending
- 2021-08-12 US US18/040,894 patent/US20230285411A1/en active Pending
- 2021-08-12 TW TW110129745A patent/TW202220666A/zh unknown
- 2021-08-12 KR KR1020237006743A patent/KR20230051199A/ko active Pending
- 2021-08-12 WO PCT/JP2021/029701 patent/WO2022034909A1/ja not_active Ceased
- 2021-08-12 CN CN202180044806.9A patent/CN115768433A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011013651A (ja) | 2009-07-03 | 2011-01-20 | Mitsumasa Maeda | フレキシブルディスプレイのれん |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2022034909A1 (cg-RX-API-DMAC7.html) | 2022-02-17 |
| EP4197540A4 (en) | 2024-06-19 |
| TW202220666A (zh) | 2022-06-01 |
| US20230285411A1 (en) | 2023-09-14 |
| WO2022034909A1 (ja) | 2022-02-17 |
| CN115768433A (zh) | 2023-03-07 |
| EP4197540A1 (en) | 2023-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4934653B2 (ja) | Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤 | |
| JP5174777B2 (ja) | Rhoキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤 | |
| JP2024160001A (ja) | 緑内障予防又は治療のための薬物療法 | |
| JP4482726B2 (ja) | Rhoキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤 | |
| EP1526895A2 (en) | Methods for treating carbonic anhydrase mediated disorders | |
| ES2972934T3 (es) | Combinación de sepetaprost y ripasudil para su uso en la profilaxis o tratamiento del glaucoma o hipertensión ocular | |
| EP4197540A1 (en) | Drug formulation containing sepetaprost | |
| KR20200103719A (ko) | 피리딜아미노아세트산 화합물을 함유하는 의약 제제 | |
| JP2012250951A (ja) | アデノシン誘導体とプロスタグランジン類とβ受容体遮断薬の組合せ剤 | |
| JP2012250949A (ja) | アデノシン誘導体と炭酸脱水酵素阻害剤とβ受容体遮断薬の組合せ剤 | |
| JP2012250947A (ja) | アデノシン誘導体とβ受容体遮断薬の組合せ剤 | |
| EA043474B1 (ru) | Комбинация омиденепага | |
| JP2012250952A (ja) | アデノシン誘導体とRhoキナーゼ阻害剤の組合せ剤 | |
| JP2012250948A (ja) | アデノシン誘導体と炭酸脱水酵素阻害剤の組合せ剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| D21 | Rejection of application intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |